(E)-3-Phenyl-but-2-enoyl azide | 872509-51-8

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: (E)-3-Phenyl-but-2-enoyl azide
• CAS: 872509-51-8
• 化学式: C₁₀H₉N₃O
• 分子量: 187.201
• InChiKey: QVBLJEUGENMPJY-BQYQJAHWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.93
• 重原子数：
  14.0
• 可旋转键数：
  2.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  65.83
• 氢给体数：
  0.0
• 氢受体数：
  1.0

反应信息

• 作为反应物：
  描述：

  (E)-3-Phenyl-but-2-enoyl azide 以 甲苯 为溶剂， 反应 1.0h， 生成 [(E)-1-isocyanatoprop-1-en-2-yl]benzene
  参考文献：
  名称：

  Synthesis and evaluation of ureido and vinylureidopenicillins as inhibitors of intraruminal lactic acid production

  摘要：

  A series of 14 vinylureidopenicillins and a series of 9 ureidopenicillins were prepared by reaction of 6-aminopenicillanic acid with vinyl isocyanates and isocyanates. These compounds were evaluated for their potential to protect ruminants against lactic acidosis. The compounds were tested for inhibition of in vitro ruminal lactic and propionic acid production, and six compounds inhibited lactic acid production to less than 10% of control at doses of 0.31 microgram/mL or lower, whereas they did not inhibit propionic acid production at doses greater than 10 micrograms/mL. The most active compounds also were screened for general antibacterial activity and were found to be weakly active against Gram-positive bacteria. The structure--activity relationships are discussed for both series. Triethylammonium 6-[3[2-(4-tert-butylphenyl)vinyl]ureido]penicillanate (4) was chosen for evaluation as an inhibitor of intraruminal lactic acidosis in vivo.

  DOI：

  10.1021/jm00142a024
• 作为产物：
  描述：

  (E)-3-phenylbut-2-enoyl chloride 在 sodium azide 作用下， 以 水 为溶剂， 反应 1.0h， 生成 (E)-3-Phenyl-but-2-enoyl azide
  参考文献：
  名称：

  Synthesis and evaluation of ureido and vinylureidopenicillins as inhibitors of intraruminal lactic acid production

  摘要：

  A series of 14 vinylureidopenicillins and a series of 9 ureidopenicillins were prepared by reaction of 6-aminopenicillanic acid with vinyl isocyanates and isocyanates. These compounds were evaluated for their potential to protect ruminants against lactic acidosis. The compounds were tested for inhibition of in vitro ruminal lactic and propionic acid production, and six compounds inhibited lactic acid production to less than 10% of control at doses of 0.31 microgram/mL or lower, whereas they did not inhibit propionic acid production at doses greater than 10 micrograms/mL. The most active compounds also were screened for general antibacterial activity and were found to be weakly active against Gram-positive bacteria. The structure--activity relationships are discussed for both series. Triethylammonium 6-[3[2-(4-tert-butylphenyl)vinyl]ureido]penicillanate (4) was chosen for evaluation as an inhibitor of intraruminal lactic acidosis in vivo.

  DOI：

  10.1021/jm00142a024

文献信息

• Inhibitors of Hepatitis C Virus
  申请人：D'Andrea Stanley

  公开号：US20080107623A1

  公开（公告）日：2008-05-08

  Macrocyclic peptides are disclosed having the general formula: wherein R 3 , R 3 ′, R 4 , R 6 , R′, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

  揭示了具有一般公式的大环肽： 其中描述了R3、R3'、R4、R6、R'、X、Q和W。还公开了包含这些化合物的组合物以及使用这些化合物抑制HCV的方法。
• Hepatitis C virus inhibitors
  申请人：Sin Ny

  公开号：US20060183694A1

  公开（公告）日：2006-08-17

  The present disclosure is generally directed to antiviral compounds, and more specifically directed to compounds which inhibit the function of the NS3 protease (also referred to herein as “serine protease”) encoded by Hepatitis C virus (HCV), compositions comprising such compounds, and methods for inhibiting the function of the NS3 protease.

  本公开涉及抗病毒化合物，更具体地涉及抑制丙型肝炎病毒（HCV）编码的NS3蛋白酶（本文中也称为“丝氨酸蛋白酶”）功能的化合物，包括这种化合物的组合物，以及抑制 蛋白酶功能的方法。
• Decarboxylative Enamide Synthesis from Carboxylic Acid and Alkenyl Isocyanate
  作者：Rui Wang、Wenbo H. Liu

  DOI：10.1021/acs.orglett.3c01682

  日期：2023.7.21

  protocol to access the enamide via employing carboxylic acid and alkenyl isocyanate as the precursors promoted by DMAP without involving any metal catalysts and dehydration reagents. This protocol is simple and practical and tolerates numerous functional groups. Considering the simplicity, the ready availability of both starting materials, and the significance of the enamides, we expect that this reaction

  在此，我们报道了一种通过使用羧酸和烯基异氰酸酯作为 DMAP 促进的前体来获取烯酰胺的方案，而不涉及任何金属催化剂和脱水试剂。该协议简单实用，并且能够容忍多种官能团。考虑到简单性、两种起始材料的现成性以及烯酰胺的重要性，我们预计该反应将得到广泛的应用。